Gilead’s Covid drug is mediocre. It will be a blockbuster anyway.

Gilead’s Covid drug is mediocre. It will be a blockbuster anyway. The company said that by December, it expected to have produced enough drug to treat 2 million patients and that it was studying an inhaled form of the drug that could expand its use to outpatients. https://ift.tt/eA8V8J